Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Weighted Average) (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 4 years of Shares Outstanding (Weighted Average) data on record, last reported at $46.1 million in Q4 2016.

  • For Q4 2016, Shares Outstanding (Weighted Average) rose 2.26% year-over-year to $46.1 million; the TTM value through Dec 2016 reached $46.1 million, up 2.26%, while the annual FY2016 figure was $46.1 million, 2.26% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $46.1 million in Q4 2016 per AMPH's latest filing, up from $45.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $46.1 million in Q4 2016 and bottomed at $38769.0 in Q1 2014.
  • Average Shares Outstanding (Weighted Average) over 4 years is $34.1 million, with a median of $44.7 million recorded in 2015.
  • Peak YoY movement for Shares Outstanding (Weighted Average): plummeted 99.9% in 2014, then soared 114942.95% in 2015.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $38.7 million in 2013, then tumbled by 99.88% to $44644.0 in 2014, then surged by 100887.81% to $45.1 million in 2015, then grew by 2.26% to $46.1 million in 2016.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $46.1 million in Q4 2016, $45.4 million in Q3 2016, and $45.0 million in Q2 2016.